Recent Quotes

My Watchlist

Indicators

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >

Novo Nordisk and Eli Lilly rival soars 26% after promising test results

February 26, 2024

What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs

February 16, 2024

Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

February 10, 2024

Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease

February 06, 2024

Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply

February 05, 2024

Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars

January 31, 2024

5 things to know before the stock market opens Monday

January 29, 2024

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

January 26, 2024

The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space

January 17, 2024

People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey

January 08, 2024

Biden administration's Medicare drug price negotiations will face major tests in 2024

December 28, 2023

Here are the big health sector themes to watch next year

December 22, 2023

Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma

December 20, 2023

5 things to know before the stock market opens Monday

December 18, 2023

The weight loss drug boom isn't over yet — here's what to expect in the year ahead

December 17, 2023

Patients regain weight after stopping Eli Lilly's Zepbound, study says

December 11, 2023

Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages

December 05, 2023

An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024

December 05, 2023

Cramer says the growing popularity of weight loss drugs brings new investing opportunities

December 04, 2023

Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops

December 02, 2023

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

December 01, 2023

Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs

November 30, 2023

Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says

November 27, 2023

Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members

November 13, 2023

Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success

November 13, 2023

5 things to know before the stock market opens Monday

November 13, 2023

Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events

November 11, 2023

Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index

November 10, 2023

Cramer's Lightning Round: Buy AutoZone

November 09, 2023

FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug

November 08, 2023

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search Hotels in Sausalito

Find A Business

or Browse Listings

Latest News about Novo Nordisk A/S